Berlin, Germany

Matthias Paschke

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Matthias Paschke: Innovator in Biopharmaceuticals

Introduction

Matthias Paschke is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biopharmaceuticals, holding a total of 6 patents. His work focuses on innovative compounds and their applications in medical science.

Latest Patents

Among his latest patents is a compound comprising a fibroblast activation protein ligand and its use. This invention relates to a compound that includes a cyclic peptide and a chelator, showcasing his expertise in developing novel therapeutic agents. Another notable patent is a conjugate comprising a neurotensin receptor ligand, which details a complex structure designed for targeted binding to specific biological targets. This invention emphasizes the intricate design of targeting moieties and adapter moieties, highlighting his innovative approach to drug development.

Career Highlights

Throughout his career, Matthias has worked with notable companies such as Baxalta GmbH and 3B Pharmaceuticals GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Matthias has collaborated with esteemed colleagues, including Frank Osterkamp and Ulrich Reineke. These partnerships have further enhanced his research capabilities and have led to significant advancements in his field.

Conclusion

Matthias Paschke is a distinguished inventor whose work in biopharmaceuticals continues to impact the industry. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…